Related Experiment Video
Updated: Sep 24, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Risk of Stroke With Mitral Stenosis: The Underlying Mechanism, Treatment, and Prevention
Hamza Islam1, Sri Madhurima Puttagunta2, Rabia Islam1
1Research, Faisalabad Medical University, Faisalabad, PAK.
Insights
Mitral stenosis increases stroke risk, with mitral annular calcification being a key predictor. This review covers risk factors, assessment, and therapies including newer oral anticoagulants and non-pharmacological options for stroke prevention.
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- Mitral stenosis (MS) involves mitral valve narrowing, increasing stroke risk.
- Common risk factors include mitral annular calcification (MAC), diabetes mellitus (DM), hypertension (HTN), and hyperlipidemia.
- Thrombus formation is driven by endothelial damage, hypercoagulability, and left atrial blood stasis.
Purpose of the Study:
- To review mechanisms of thromboembolism in MS.
- To identify stroke risk factors and assessment models in MS patients.
- To evaluate current and novel therapies for stroke prevention in MS.
Main Methods:
- Comprehensive literature review on MS and stroke.
- Analysis of risk factors, including MAC as an independent predictor.
- Evaluation of newer oral anticoagulants (NOACs) and non-pharmacological therapies.
Main Results:
- MAC is identified as an independent predictor of stroke in MS.
- Review encompasses mechanisms, risk factors, and assessment strategies for stroke in MS.
- Efficacy and safety of NOACs (dabigatran, edoxaban, apixaban, rivaroxaban) and interventions like LAA ligation/occlusion are discussed.
Conclusions:
- Understanding MS-related stroke mechanisms is crucial for risk stratification.
- NOACs and non-pharmacological approaches offer potential for stroke risk reduction.
- Further research on optimal therapeutic strategies is warranted.
Abstract:
Mitral stenosis (MS), a valvular heart disease, is defined by the narrowing of the mitral valve orifice. The common risk factors for stroke include mitral annular calcification (MAC), diabetes mellitus (DM), male gender, hypertension (HTN), hyperlipidemia, and obesity. Endothelial damage, hypercoagulability, and blood stasis in the left atrium promote the development of the thrombus. Among all the risk factors described, MAC is the independent predictor of stroke. The complicated mechanisms responsible for thromboembolism, predisposing factors for thromboembolism, the risk of cerebrovascular accident (CVA) in MS patients, advanced standardized assessment models for identifying those at risk for stroke, and the possible advantages and disadvantages of available therapies have all been discussed in this review article. We have also discussed newer oral anticoagulants (NOACs) like dabigatran, edoxaban, apixaban, and rivaroxaban. Non-pharmacological therapies are also highlighted such as left atrial appendage ligation and occlusion devices. We also conducted a thorough review of the literature on the efficacy and safety of various NOACs in reducing the risk of stroke.
More Related Videos
07:42An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis IV: Nursing Management
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse I: Introduction